Clinical Trial: The related factors of time to recurrent biliary obstruction after the self-expanded metallic stent placement for the distal malignant biliary obstruction (Japan)

Tokyo, Aug. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058935) titled 'The related factors of time to recurrent biliary obstruction after the self-expanded metallic stent placement for the distal malignant biliary obstruction' on Aug. 29.

Study Type: Observational

Primary Sponsor: Institute - Matsunami General Hospital

Condition: Condition - The case of the distal malignant biliary obstruction with self-expanded metallic stent placement. Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - To evaluate the related factors of TRBO of SEMS for the distal malignant biliary obstruction. Basic objectives2 - Safety,Efficacy

Eligibility: Age-lower limit - 18 years-old = Gender - Male and Female Key inclusion criteria - >17-years-old The case of distal malignant biliary obstruction with SEMS placement. Key exclusion criteria - The patients who are otherwise judged by the investigator to be ineligible to participate in the study. Target Size - 600

Recruitment Status: Recruitment status - Suspended Date of protocol fixation - 2022 Year 01 Month 07 Day Date of IRB - 2021 Year 09 Month 13 Day Anticipated trial start date - 2022 Year 01 Month 07 Day Last follow-up date - 2030 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067402

Disclaimer: Curated by HT Syndication.